Differences in regulatory pathways identify subgroups of T cell-derived Th2 cytokines

Clinical and Experimental Immunology

Volumn 121, Issue 1, 2000, Pages 86-93

  Rafiq, K ^a   Bullens, D M A ^a   Kasran, A ^a   Lorre K ^b   Ceuppens, J L ^a   Van Gool, Stefaan W ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b INNOGENETICS   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Calcium; CD28; IL 2; Protein kinase C; Th2 cytokine production

Indexed keywords

B7 ANTIGEN; CALCINEURIN; CD28 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PHORBOL MYRISTATE; PHOSPHATASE; PROTEIN KINASE C;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STIMULATION; EFFECTOR CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ADULT; ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CALCIUM; CELLS, CULTURED; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED DBA; MIDDLE AGED; T-LYMPHOCYTES; TH2 CELLS; TUMOR CELLS, CULTURED;

EID: 0033938680     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01273.x     Document Type: Article

References (38)

1. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
2. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994; 12:635-73.
3. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
4. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996; 9:532-62.
5. Seder RA, Germain RN, Linsley PS, Paul WE. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J Exp Med 1994; 179:299-304.
6. Walter H, Schepens S, Van Wauwe J, de Boer M. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines. Eur Cytokine Netw 1994; 5:13-21.
7. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-58.
8. Van Gool SW, Vandenberghe P, de Boer M, Ceuppens JL. CD80, CD86 and CD40 provide accessory signals in a multiple step T cell activation model. Immunol Rev 1996; 153:47-83.
9. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 1987; 7:4472-81.
10. Van Gool SW, de Boer M, Ceuppens JL. CD28 ligation by mAb or B7/BB1 provides an accessory signal for the CsA-resistant generation of cytotoxic T cell activity. J Immunol 1993; 150:3254-63.
11. Van Gool SW, Kasran A, Wallays G, de Boer M, Ceuppens JL. Accessory signalling by B7-1 for T cell activation induced by anti-CD2: evidence for IL-2-independent CTL generation and CsA-resistant cytokine production. Scand J Immunol 1995; 41:23-30.
12. Ra C, Jouvin ME, Blank U, Kinet JP. A macrophage Fcγ receptor and the mast cell receptor for IgE share an identical subunit. Nature 1989; 341:752-4.
13. Ceuppens JL, Baroja ML, Lorré K, Van Damme J, Billiau A. Human T cell activation with PHA: the function of IL-6 as an accessory signal. J Immunol 1988; 141:3868-74.
14. Bullens DMA, Kasran A, Peng X, Lorre K, Ceuppens JL. Effects of anti-IL-4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL-4 production by T cells from non-atopic donors. Clin Exp Immunol 1998; 113:320-6.
15. Van Gool SW, Zhang Y, Kasran A, de Boer M, Ceuppens JL. T helper-independent activation of human CD8(+) cells: the role of CD28 costimulation. Scand J Immunol 1996; 44:21-29.
16. Bird JJ, Brown DR, Mullen AC et al. Helper T cell differentiation is controlled by the cell cycle. Immunity 1998; 9:229-37.
17. Kubo M, Kincaid RL, Ransom JT. Activation of the interleukin-4 gene is controlled by the unique calcineurin-dependent transcriptional factor NF(P). J Biol Chem 1994; 269:19441-6.
18. Beals CR, Clipstone NA, Ho SN, Crabtree GR. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev 1997; 11:824-34.
19. Aune TM, Flavell RA. Differential expression of transcription directed by a discrete NF-AT binding element from the IL-4 promoter in naive and effector CD4 T cells. J Immunol 1997; 159:36-43.
20. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15:707-47.
21. Zheng WP, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89:587-96.
22. Umland SP, Razac S, Shah H, Nahrebne DK, Egan RW, Billah MM. Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma. Am J Respir Cell Mol Biol 1998; 18:631-42.
23. Schandené L, Alonso-Vega C, Willems F et al. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 1994; 152:4368-74.
24. van der Pouw Kraan TCTMV, Boeije LCM, Troon JTM, Rutschmann SK, Wijdenes J, Aarden LA. Human IL-13 production is negatively influenced by CD3 engagement - enhancement of IL-13 production by cyclosporin A. J Immunol 1996; 156:1818-23.
25. Valentine JE, Sewell WA. Induction of IL-5 expression by IL-2 is resistant to the immunosuppressive agents cyclosporin A and rapamycin. Int Immunol 1997; 9:975-82.
26. Mori A, Suko M, Kaminuma O et al. IL-2-induced IL-5 synthesis, but not proliferation, of human CD4+ T cells is suppressed by FK506. J Immunol 1997; 158:3659-65.
27. Houssiau FA, Schandené L, Stevens M et al. A cascade of cytokines is responsible for IL-9 expression in human T cells: involvement IL-2, IL-4, and IL-10. J Immunol 1995; 154:2624-30.
28. Holter W, Majdic O, Kalthoff FS, Knapp W. Regulation of interleukin-4 production in human mononuclear cells. Eur J Immunol 1992; 22:2765-7.
29. de Boer M, Kasran A, Kwekkeboom J, Walter H, Vandenberghe P, Ceuppens JL. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur J Immunol 1993; 23:3120-5.
30. Minty A, Chalon P, Derocq JM et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-50.
31. Zurawski G, De Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19-26.
32. De Waal Malefyt R, Abrams JS, Zurawski SM et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 1995; 7:1405-16.
33. Jung T, Wijdenes J, Neumann C, De Vries JE, Yssel H. Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12. Eur J Immunol 1996; 26:571-7.
34. Palmer EM, van Seventer GA. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals. J Immunol 1997; 158:2654-62.
35. Berth Jones J, Graham Brown RA, Marks R et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997; 136:76-81.
36. Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Eng J Med 1992; 326:298-304.
37. Huang SK, Xiao HQ, Kleine-Tebbe J et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995; 155:2688-94.
38. Nizankowska E, Soja J, Pinis G et al. Treatment of steroid-dependent bronchial asthma with cyclosporin. Eur Respir J 1995; 8:1091-9.